Moreover, the results of cellular experiments showed that IGFBP3 was significantly up‐regulated during HSC activation; animal experiments revealed that silencing IGFBP3 suppressed the activation of HSCs and the development of hepatic fibrosis.25 This evidence concerns the gene IGFBP3 and Hepatic fibrosis.